✦ LIBER ✦

Salvage therapies in women failing first-line treatment with FEC (fluorouracil-epirubicin cyclophosphamide) for advanced breast cancer

✍ Scribed by K. Porkka; C. Blomqvist; S. Pyrhönen; P. Rissanen; I. Elomaa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

646 - Mitoxantrone (N) vs. 5-fluorouraci

✍ G. von minckwitz; E. Heldemann; R. Souchon; H. Samonigg; W.D. Hirschmann; H. Bod 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 416 KB

Cyclophosphamide, epirubicin, high-dose

✍ Zaniboni, Alberto; Simoncini, Edda; Marpicati, Patrizia; Montini, Elisabetta; Fe 📂 Article 📅 1989 🏛 Elsevier Science ⚖ 553 KB

FEC (5-fluorouracil, epidoxorubicin and

✍ P. Pacini; M. Rinaldini; R. Algeri; A. Guarneri; E. Tucci; G. Barsanti; B. Neri; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 205 KB

Gemcitabine, epirubicin and paclitaxel (

✍ T. Brodowicz; S. Beslija; J. Cervek; Z. Mrsic-Krmpotic; I. Tchernozemsky; C. Wil 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 166 KB

Results of first line endocrine therapy

✍ W. Jonat; M. Kaufmann; R. Blamey; A. Howell; J. Collins; A. Coates; D. Eiermann; 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 319 KB

Efficacy of tamoxifen following anastroz

✍ B. Thürlimann; J.F.R. Robertson; J.M. Nabholtz; A. Buzdar; J. Bonneterre 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 247 KB